Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Endocrine System Diseases × Gemcitabine × 1 year × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 105 Urinary Bladder Neoplasms 48 Carcinoma, Non-Small-Cell Lung 44 Cholangiocarcinoma 29 Biliary Tract Neoplasms 29 Neoplasm Metastasis 27 Ovarian Neoplasms 23 Lymphoma, Large B-Cell, Diffuse 23 Breast Neoplasms 23 Nasopharyngeal Carcinoma 20 Carcinoma, Transitional Cell 20 Lung Neoplasms 19 Neoplasms 18 Non-Muscle Invasive Bladder Neoplasms 17 Colorectal Neoplasms 17 Recurrence 16 Triple Negative Breast Neoplasms 15 Gallbladder Neoplasms 15 Fallopian Tube Neoplasms 12 Sarcoma 10 Hodgkin Disease 10 Uterine Cervical Neoplasms 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Bile Duct Neoplasms 9 Lymphoma, Non-Hodgkin 8 Lymphoma 8 Stomach Neoplasms 7 Adenocarcinoma 7 Nasopharyngeal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5

Interventions

selpercatinib 2 repotrectinib 1 pralsetinib 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡